Greater Manchester residents are being encouraged to take part in a research study at MREH that aims to improve the diagnosis and treatment of conditions associated with sight loss.
Research delivered through the NIHR Manchester Biomedical Research Centre (BRC) has contributed to improved diagnostic guidelines for identifying and managing asthma, announced by NICE last week.
New research at Wythenshawe Hospital, has the potential to limit the development of antibiotic resistance while improving patient outcomes, when treating very ill patients with pneumonia and sepsis.
A ground-breaking genetic test that could prevent critically ill newborn babies going deaf if treated with a commonly used antibiotic, is being trialled across 14 NHS neonatal units.
On Tuesday 10 September 2024, MFT's Innovation Team brought together colleagues from across the NHS, academia and industry to showcase our innovation offer at MFT.
Researchers have shown that their system, developed at MFT, can identify more breast cancer patients who are eligible for testing for inherited faulty genes that can cause breast cancer.
Researchers at The University of Manchester in collaboration with MFT are launching a new Cystic Fibrosis Innovation Hub to accelerate the development of new tests and treatments for lung infections.